Immunocore Holdings (IMCR) Non Operating Income (2023 - 2026)

Immunocore Holdings has disclosed Non Operating Income across 4 years of filings, most recently posting $1.8 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $1.8 million, down 67.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (down 19.25% YoY), and the FY2025 annual result was $19.7 million, up 38.95% from the prior year.
• Non Operating Income came in at $1.8 million for Q1 2026 at Immunocore Holdings, down from $4.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $9.0 million in Q3 2024 to a low of -$325000.0 in Q1 2023.
• The 4-year median for Non Operating Income is $1.8 million (2026), against an average of $2.7 million.
• Across the five-year window, Non Operating Income jumped 4767.71% in 2024 and plunged 67.53% in 2026, its largest moves.
• Immunocore Holdings' Non Operating Income stood at -$191000.0 in 2023, then surged by 619.9% to $993000.0 in 2024, then surged by 353.58% to $4.5 million in 2025, then plunged by 60.57% to $1.8 million in 2026.
• The last three Non Operating Income figures came in at $1.8 million (Q1 2026), $4.5 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.